Consolidated figures · ₹ crore
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 1,040 | 1,341 | 1,631 | 1,277 | 1,404 | 1,608 | 1,752 | 2,101 | 2,564 | |
| COGS | 663 | 827 | 1,008 | 751 | 831 | 961 | 1,009 | 1,131 | 1,317 |
| Gross profit | 377 | 514 | 623 | 525 | 573 | 647 | 743 | 970 | 1,247 |
| 247 | 301 | 355 | 318 | 379 | 461 | 418 | 516 | 600 | |
| 130 | 213 | 268 | 208 | 194 | 186 | 325 | 454 | 646 | |
| OPM % | 12.5% | 15.9% | 16.4% | 16.3% | 13.8% | 11.6% | 18.5% | 21.6% | 25.2% |
| Depreciation | 43 | 47 | 63 | 71 | 75 | 108 | 123 | 132 | 144 |
| Interest | 24 | 29 | 41 | 21 | 24 | 68 | 98 | 88 | 82 |
| 16 | 15 | 67 | 43 | 38 | 21 | 26 | 21 | 19 | |
| Profit before tax | 79 | 152 | 231 | 158 | 133 | 31 | 130 | 255 | 440 |
| Tax | 26 | 57 | 55 | 41 | 35 | 10 | 34 | 70 | 123 |
| Tax % | 32.5% | 37.8% | 23.8% | 26.1% | 26.6% | 31.5% | 26.5% | 27.4% | 28% |
| 53 | 94 | 176 | 117 | 97 | 21 | 95 | 185 | 317 | |
| PAT margin % | 5.1% | 7% | 10.8% | 9.2% | 6.9% | 1.3% | 5.5% | 8.8% | 12.4% |
| EPS (₹) | 13.7 | 24.1 | 45.1 | 0 | 24.9 | 5.5 | 24.4 | 47.9 | 83.9 |
| EPS adjusted (₹) | — | — | 45.1 | 37.4 | 24.9 | 6.3 | 24.4 | 47.3 | 81.1 |
| 11% | 10.4% | 3.3% | — | 8% | 0% | 8.2% | 10.4% | 11.9% | |
| Annual report | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 39 | 39 | 39 | 39 | 39 | 39 | 39 |
| Reserves | 573 | 683 | 773 | 790 | 885 | 1,064 | 1,373 |
| Minority interest | — | — | 7 | 6 | 17 | 14 | 28 |
| 481 | 496 | 834 | 1,061 | 981 | 1,123 | 1,010 | |
| 291 | 322 | 523 | 495 | 421 | 550 | 719 | |
| Total equity & liabilities | 1,384 | 1,540 | 2,176 | 2,391 | 2,343 | 2,791 | 3,170 |
| 566 | 567 | 651 | 1,017 | 1,034 | 1,156 | 1,169 | |
| CWIP | 30 | 174 | 364 | 95 | 89 | 127 | 298 |
| Investments | 1 | 0 | 12 | 7 | 40 | 8 | 55 |
| 786 | 798 | 1,150 | 1,273 | 1,179 | 1,499 | 1,649 | |
| Total assets | 1,384 | 1,540 | 2,176 | 2,391 | 2,343 | 2,791 | 3,170 |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2020 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Aroma Chemicals | 1,324.11 | 160.38 | — | 750.77 |
| Oleo Chemicals and Intermdiate Neutraceuticals | 306.49 | 44.87 | — | 79.53 |
₹ crore by fiscal year
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 216 | 172 | 5 | 49 | 354 | 281 | 550 | |
| -174 | -242 | -320 | -133 | -180 | -294 | -358 | |
| 29 | 0 | 333 | 72 | -171 | 39 | -198 | |
| Net cash flow | 72 | -69 | 17 | -12 | 4 | 26 | -6 |
| Free cash flow | 46 | -71 | -304 | -91 | 204 | -18 | 230 |
| CFO / Operating profit % | 80.6% | 82.9% | 2.5% | 26.2% | 109.1% | 62% | 85.1% |